HEADER VIRAL PROTEIN 14-SEP-12 2LYB TITLE STRUCTURE OF HIV-1 MYR(-) MATRIX PROTEIN IN COMPLEX WITH 1,2- TITLE 2 DIOCTANOYL-SN-PHOSPHATIDYL-L-SERINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: MATRIX PROTEIN P17; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: MA, GAG-POL POLYPROTEIN; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS TYPE 1; SOURCE 3 ORGANISM_TAXID: 11698; SOURCE 4 STRAIN: NEW YORK-5 ISOLATE; SOURCE 5 GENE: GAG-POL; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR: PET21 KEYWDS GAG, MATRIX, PLASMA MEMBRANE, LIPID, VIRAL PROTEIN EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR J.VLACH,J.SAAD REVDAT 3 03-APR-13 2LYB 1 JRNL REVDAT 2 06-MAR-13 2LYB 1 JRNL REVDAT 1 13-FEB-13 2LYB 0 JRNL AUTH J.VLACH,J.S.SAAD JRNL TITL TRIO ENGAGEMENT VIA PLASMA MEMBRANE PHOSPHOLIPIDS AND THE JRNL TITL 2 MYRISTOYL MOIETY GOVERNS HIV-1 MATRIX BINDING TO BILAYERS. JRNL REF PROC.NATL.ACAD.SCI.USA V. 110 3525 2013 JRNL REFN ISSN 0027-8424 JRNL PMID 23401539 JRNL DOI 10.1073/PNAS.1216655110 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CYANA 2.1 REMARK 3 AUTHORS : GUNTERT, MUMENTHALER AND WUTHRICH REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2LYB COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 24-JAN-13. REMARK 100 THE RCSB ID CODE IS RCSB102984. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 308 REMARK 210 PH : 5.5 REMARK 210 IONIC STRENGTH : 50 REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 0.4 MM [U-95% 13C] MA, 0.8-1.0 REMARK 210 MM 1,2-DIOCTANOYL-SN-GLYCERO-3-PHOSPHO-L-SERINE, SODIUM SALT, 50 REMARK 210 MM SODIUM PHOSPHATE, 2 MM DTT, 90% H2O/10% D2O; 0.4-1.0 MM [U-95% REMARK 210 13C; U-95% 15N] MA, 0.8-1.0 MM 1,2-DIOCTANOYL-SN-GLYCERO-3- REMARK 210 PHOSPHO-L-SERINE, SODIUM SALT, 50 MM SODIUM PHOSPHATE, 2 MM DTT, REMARK 210 90% H2O/10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 3D 13C-EDITED/13C-FILTERED REMARK 210 NOESY; 3D HCCH-TOCSY; 2D 1H-13C REMARK 210 HSQC; 3D HNCA; 3D HN(CO)CA; 3D REMARK 210 HNCACB; 3D CBCA(CO)NH; 3D 1H-15N REMARK 210 TOCSY; 3D 1H-15N NOESY; 3D 1H-13C REMARK 210 NOESY; 2D 1H-15N HSQC REMARK 210 SPECTROMETER FIELD STRENGTH : 700 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE II REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : CYANA 2.1, TOPSPIN, NMRPIPE, REMARK 210 CCPN_ANALYSIS REMARK 210 METHOD USED : SIMULATED ANNEALING, TORSION REMARK 210 ANGLE DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 465 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 MODELS 1-20 REMARK 465 RES C SSSEQI REMARK 465 HIS A 133 REMARK 465 HIS A 134 REMARK 465 HIS A 135 REMARK 465 HIS A 136 REMARK 465 HIS A 137 REMARK 465 HIS A 138 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 SER A 6 98.58 -162.11 REMARK 500 1 LYS A 114 30.94 -98.57 REMARK 500 1 GLN A 116 -72.16 -101.31 REMARK 500 1 ALA A 118 -38.93 -169.44 REMARK 500 2 GLN A 90 -73.17 -101.77 REMARK 500 2 ARG A 91 -35.10 -179.24 REMARK 500 2 ASP A 93 55.17 -114.57 REMARK 500 2 ASP A 121 62.72 -114.43 REMARK 500 2 GLN A 130 -65.05 -171.84 REMARK 500 2 ASN A 131 179.05 62.63 REMARK 500 3 ALA A 3 -64.89 -155.75 REMARK 500 3 SER A 9 -173.26 -68.20 REMARK 500 3 GLN A 90 -72.87 -100.46 REMARK 500 3 ARG A 91 -35.76 -179.26 REMARK 500 3 ASP A 93 63.50 -115.06 REMARK 500 3 GLN A 127 78.93 -171.52 REMARK 500 4 ALA A 3 -45.34 -143.80 REMARK 500 4 GLN A 90 -72.85 -76.27 REMARK 500 4 ARG A 91 -35.18 -179.19 REMARK 500 4 ASP A 93 59.29 -109.80 REMARK 500 4 LYS A 114 38.43 -171.87 REMARK 500 4 GLN A 117 -56.21 -129.54 REMARK 500 4 ALA A 119 37.27 -151.55 REMARK 500 4 ALA A 120 -41.67 -132.75 REMARK 500 4 THR A 122 171.50 62.84 REMARK 500 4 ASN A 124 172.57 -58.00 REMARK 500 4 ASN A 131 72.45 -161.44 REMARK 500 5 ALA A 5 119.02 -171.92 REMARK 500 5 GLN A 116 35.29 -146.74 REMARK 500 5 ALA A 119 32.28 -169.98 REMARK 500 5 ALA A 120 29.01 -146.63 REMARK 500 5 ASP A 121 42.95 -101.42 REMARK 500 6 SER A 6 -175.16 59.44 REMARK 500 6 GLN A 90 -74.15 -78.73 REMARK 500 6 ARG A 91 -35.38 -179.28 REMARK 500 6 ASP A 93 53.68 -110.44 REMARK 500 6 GLN A 116 -72.00 -96.69 REMARK 500 6 ALA A 118 -43.02 -168.99 REMARK 500 6 THR A 122 73.15 -113.74 REMARK 500 6 ASN A 125 168.09 62.48 REMARK 500 6 VAL A 128 172.31 -58.25 REMARK 500 6 ASN A 131 177.65 61.47 REMARK 500 7 SER A 9 -172.35 -65.24 REMARK 500 7 GLN A 90 -72.88 -100.73 REMARK 500 7 ARG A 91 -35.30 -179.23 REMARK 500 7 ASP A 93 68.43 -117.27 REMARK 500 7 THR A 122 -170.87 51.40 REMARK 500 8 ALA A 3 176.77 -56.18 REMARK 500 8 SER A 9 -172.93 -66.45 REMARK 500 8 LYS A 27 107.81 -59.68 REMARK 500 REMARK 500 THIS ENTRY HAS 137 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 8SP A 300 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 18716 RELATED DB: BMRB REMARK 900 RELATED ID: 2LYA RELATED DB: PDB DBREF 2LYB A 2 132 UNP P12497 POL_HV1N5 2 132 SEQADV 2LYB HIS A 133 UNP P12497 EXPRESSION TAG SEQADV 2LYB HIS A 134 UNP P12497 EXPRESSION TAG SEQADV 2LYB HIS A 135 UNP P12497 EXPRESSION TAG SEQADV 2LYB HIS A 136 UNP P12497 EXPRESSION TAG SEQADV 2LYB HIS A 137 UNP P12497 EXPRESSION TAG SEQADV 2LYB HIS A 138 UNP P12497 EXPRESSION TAG SEQRES 1 A 137 GLY ALA ARG ALA SER VAL LEU SER GLY GLY GLU LEU ASP SEQRES 2 A 137 LYS TRP GLU LYS ILE ARG LEU ARG PRO GLY GLY LYS LYS SEQRES 3 A 137 GLN TYR LYS LEU LYS HIS ILE VAL TRP ALA SER ARG GLU SEQRES 4 A 137 LEU GLU ARG PHE ALA VAL ASN PRO GLY LEU LEU GLU THR SEQRES 5 A 137 SER GLU GLY CYS ARG GLN ILE LEU GLY GLN LEU GLN PRO SEQRES 6 A 137 SER LEU GLN THR GLY SER GLU GLU LEU ARG SER LEU TYR SEQRES 7 A 137 ASN THR ILE ALA VAL LEU TYR CYS VAL HIS GLN ARG ILE SEQRES 8 A 137 ASP VAL LYS ASP THR LYS GLU ALA LEU ASP LYS ILE GLU SEQRES 9 A 137 GLU GLU GLN ASN LYS SER LYS LYS LYS ALA GLN GLN ALA SEQRES 10 A 137 ALA ALA ASP THR GLY ASN ASN SER GLN VAL SER GLN ASN SEQRES 11 A 137 TYR HIS HIS HIS HIS HIS HIS HET 8SP A 300 75 HETNAM 8SP O-[(R)-{[(2R)-2,3-BIS(OCTANOYLOXY)PROPYL]OXY}(HYDROXY) HETNAM 2 8SP PHOSPHORYL]-L-SERINE FORMUL 2 8SP C22 H42 N O10 P HELIX 1 1 SER A 9 ILE A 19 1 11 HELIX 2 2 LYS A 30 PHE A 44 1 15 HELIX 3 3 ASN A 47 THR A 53 5 7 HELIX 4 4 GLU A 55 GLN A 65 1 11 HELIX 5 5 SER A 67 GLY A 71 5 5 HELIX 6 6 SER A 72 GLN A 90 1 19 HELIX 7 7 ASP A 96 SER A 111 1 16 SITE 1 AC1 3 PHE A 44 ILE A 60 LEU A 64 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1